Sartorius Ag (SARTF) 285.0000 $SARTF
Sartorius to Implement Stock Split on June 13, 2016
BusinessWire - Thu Jun 02, 2:10PM CDT
As approved by the Annual Shareholders' Meeting of Sartorius AG (FWB:SRT) on April 7, the capital increase by use of retained earnings to perform a stock split will be implemented on June 13, 2016. Every shareholder will receive three additional shares of the same type per share held, without an additional payment. The stock split is intended to encourage trading with Sartorius shares and make them attractive to even broader groups of investors.
SRT: 4.30 (-0.06)
Agile MDM for Global Multi-Channel PIM - Case Study to be Presented at International MDM Summit, London May 16th - 19th
PRWeb - Mon Apr 25, 2:10PM CDT
Riversand Technologies, a worldwide leader in Multi-Domain Master Data Management (MDM), Product Information Management, and Data Quality solutions, will be sponsoring the MDM Summit and DG Conference in London, May 16th - 19th. Nicholas Rioux, CTO & Senior Partner at enscight, and Colin Price, PIM Manager at Sartorius, a Riversand client will present "Agile MDM for Global Multi-Channel PIM" at the event.
Virus Filtration Market - Global Forecast to 2020 - Key Players are Lonza Group, Sigma-Aldrich & Sartorius AG - Research and Markets
BusinessWire - Wed Apr 20, 9:22AM CDT
Research and Markets has announced the addition of the "Virus Filtration Market - Global Forecast to 2020" report to their offering.
Q1 Results: Sartorius Off to a Dynamic Start in 2016
BusinessWire - Wed Apr 20, 12:05AM CDT
--Overproportionate increase in earnings
SRT: 4.30 (-0.06)
Laboratory Glassware and Plasticware Market - Forecast to 2020 - Key Players are Corning, Eppendorf & Sartorius AG - Research and Markets
BusinessWire - Fri Apr 08, 7:56AM CDT
Research and Markets has announced the addition of the "Laboratory Glassware and Plasticware Market - Forecast to 2020" report to their offering.
Worldwide Bioreactors Market Report 2015-2019
Marketwired - Mon Apr 04, 7:23AM CDT
Research and Markets has announced the addition of the "The Worldwide Market for Bioreactors" report to their offering.
DHR: 99.03 (+0.74)
Sartorius Grows by Double Digits in Sales and Profit in 2015 - Positive Outlook for 2016 - Targets for 2020 Updated
BusinessWire - Mon Feb 01, 12:05AM CST
--Number of staff increased by around 10% to around 6,200
Global PTFE Membrane - Estimated to Reach $1.48 Billion By 2020 at a CAGR Of 7.7%
M2 - Tue Jan 12, 3:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/p7k366/ptfe_membrane) has announced the addition of the "PTFE Membrane Market - Trends & Forecasts to 2020" report to their offering. The global PTFE membrane market is estimated to reach $1.48 Billion by 2020 at a CAGR of 7.7%. The market is driven by growing prominence for water & waste water treatment and increasing penetration with evolving medical & pharmaceutical industry. The market includes two types of PTFE membrane - Hydrophobic PTFE membrane and Hydrophilic PTFE membrane. PTFE membrane is used in various applications such as water & waste water treatment, filtration, medical & pharmaceutical, textile, architecture, and others.These are the main applications considered in the report. Asia-Pacific, North America, Europe, and RoW are considered the main regions for PTFE membrane market in the report. Asia-Pacific region is dominant in the market and will be the fastest growing region for the forecast period of 2015 and 2020. The rising sale of PTFE membrane in this region is mainly driven by its strong demand in filtration application. Though the market is growing at a significant growth rate, few factors hinder the growth of the market globally. The higher price of raw materials, shift of end-user market from developed countries to the developing countries, and fluctuations in the currency exchange rates of Japan are the major restraints toward the growth of the PTFE membrane market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Membrane Market 8 Membrane Market, By Type 9 Membrane Market, By Applications 10 Membrane Market, By Region 11 Competitive Landscape 12 Company Profile - Corning Inc. - Donaldson Filtration Solutions - General Electric Company - Hyundai Micro Co., Ltd. - Layne Christensen Company - Markel Corporation - Merck Millipore - Pall Corporation - Sartorius AG - W.L. Gore & Associates, Inc. - Zeus Incorporation For more information visit http://www.researchandmarkets.com/research/p7...e_membrane
GE: 30.12 (+0.18), PLL: 127.11 (-0.01), LAYN: 8.84 (-0.09), MRK: 57.17 (+0.53), MKL: 953.37 (-9.64)
Global Pharmaceutical Membrane Market Report 2015-2019 - Growth of the Pharmaceutical Industry Drives the Market
M2 - Tue Oct 20, 5:58AM CDT
Research and Markets (http://www.researchandmarkets.com/research/s2xr6h/global_membrane) has announced the addition of the "Global Membrane Market in Pharmaceutical Industry 2015-2019" report to their offering. The global membrane market in pharmaceutical industry to grow at a CAGR of 12.46%, in terms of revenue, during 2014-2019. The report includes the present scenario and the growth prospects of the global membrane market in pharmaceutical industry for the period 2015-2019. The market can be segmented into two divisions: Technology and applications. The report covers the Americas, APAC, and EMEA markets and also includes the key vendors operating in the market. Membranes are increasingly becoming an integral part of many pharmaceutical manufacturing processes and water management systems. Various developments in membrane technology and materials such as perfluoropolymer, solid polymer electrolyte, nonporous nanofiltration and fouling-resistant multilayer membranes will positively affect the growth of the market. Also the increase in market competition is forcing vendors to increase their focus on R&D to provide high-quality and technically advanced membrane systems with additional control features that can be easily maintained by end-users throughout their life cycle. However, prices of certain products needed to carry out the research are high, making it difficult for manufacturers to manage their R&D costs. According to the report, the pharmaceutical industry involves the production, development, and marketing of medications. The industry is growing rapidly with the increasing need for and complexity of medication. The aging population, changing lifestyles, and increased chronic diseases are some of the major factors which have increased the demand for pharmaceuticals and led to the growth of this industry. Apart from this, robust economic growth, greater marketing penetration into extra-urban and rural areas, epidemiological changes, continuing rapid expansion of the private hospital sector, and increased government spending on improvements in healthcare infrastructure and spending are also driving the growth of the industry. Further, the report states that the process of setting up new production facilities for the manufacture of membrane requires high investment. Key Vendors - EMD Millipore - GEA Filtration - GE Healthcare - Koch Membrane Systems - Sartorius - Spectrum Laboratories Other Prominent Vendors - Applied Membrane Tech - Veolia Water Technologies - Pall Corporation - Graver Technologies - TAMI Industries For more information visit http://www.researchandmarkets.com/research/s2...l_membrane
PLL: 127.11 (-0.01)
Nine-month Figures for 2015: Sartorius Grows in Strong Double Digits in Order Intake, Sales Revenue and Earnings
BusinessWire - Tue Oct 20, 12:05AM CDT
--Overproportionate increase in earnings
SRT: 4.30 (-0.06)
The Worldwide Market for Bioreactors, 2019
M2 - Tue Sep 22, 4:06AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hwnvhw/the_worldwide) has announced the addition of the "The Worldwide Market for Bioreactors" report to their offering. The Worldwide Market for Bioreactors analyzes the current and potential world markets for bioreactors used generally for research and preclinical development applications, and for the manufacture of biopharmaceuticals. The cost of production can take on a significant role in the pricing of a biologic. Often, the selection of a bioreactor is a critical manufacturing decision. Selection is often done on a case-by-case basis and depends on production requirements. The industry's turn to single use bioreactors and related technology comes at a time when bioprocessors look to be flexible with production and to minimize costs. The report looks at significant trends in single use bioreactors. This report offers market forecasts of future growth to 2019. Both single use and stainless steel bioreactor markets are analyzed, with worldwide and geographic forecasts, including the U.S., Europe, Asia, Latin America, and rest of world. The report takes an in-depth look at the market, providing data on the size and growth of the total market as well as of market segments: Single Use Bioreactor Market Share by Type of Molecule, 2014 (monoclonal antibodies, vaccines, gene therapy, recombinant proteins, stem cells, others) - World Market for Bioreactors - Single Use Technology, 2014-2019 - World Market for Bioreactors - Single Use Technology, 2014-2019, by Geographic Segment - World Market for Bioreactors - Single Use Technology, 2015, by Geographic Segment - Percentage of Marketed Therapeutics by System, 2014 - Single Use Bioreactor Market Share by Vendor, 2014 - Single Use Bioreactor Usage by Process, 2014 - World Market for Bioreactors - Stainless Steel, 2014-2019 - World Market for Bioreactors - Stainless Steel, 2014-2019, by Geographic Segment - World Market for Bioreactors - Stainless Steel, 2015, by Geographic Segment Key Topics Covered: 1.0 Executive Summary 2.0 Introduction 3.0 Single Use Trends 4.0 Corporate Acquisitions 5.0 Market Developments 6.0 Market Perspective 7.0 Corporate Profiles - Applikon Biotechnology - Bioengineering AG - Broadley-James Corp. - Cellexus Ltd. - Celltainer Biotech BV - CerCell ApS - Electrolab Biotech Ltd. - Eppendorf - Finesse Solutions - GE Healthcare's Life Sciences Business - Heinrich Frings GmbH & Co. KG - Infors AG - Life Technologies - New MBR - Millipore - Pall Biopharm - PBS Biotech Inc. - Pierre Guerin Technologies Usine - Pluristem Therapeutics Inc. - Sartorius AG - Techniserv Inc. - Zeta Holding GmbH For more information visit http://www.researchandmarkets.com/research/hw..._worldwide
LIFE: 3.49 (+0.02), PSTI: 1.56 (-0.01)
Global Laboratory Automation Market 2015-2019 with Danaher, PerkinElmer, Tecan Group & Thermo Fisher Dominating
M2 - Wed Sep 09, 9:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fg5dnq/global_laboratory) has announced the addition of the "Global Laboratory Automation Market 2015-2019" report to their offering. The global laboratory automation market to grow at a CAGR of 5.48% over the period 2014-2019. This report covers the present scenario and the growth prospects of the global laboratory automation market for the period 2015-2019. To calculate the market size, the report covers revenue generated from its application in clinical laboratory and drug discovery laboratory. The report, Global Laboratory Automation Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, and North America, It also presents the vendor landscape and a corresponding detailed analysis of the major vendors in the market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market. The growing adoption of microfluidic chips or lab-on chips is one of the most significant engineering advances in recent years. Microfluidic chips are used in advanced biological research such as proteomics, genomics, and metabolic research. The global microfluidic chips market is growing because of their increased use in major laboratories worldwide. This is expected to drive the development of new laboratory automation systems over the next few years. This, in turn, should drive the growth of the global laboratory automation market during the forecast period. According to the report, the drug discovery market should experience slow growth as many pharmaceutical companies have cut down their R&D spending. However, this should not have a significant effect on the automation market in drug discovery laboratories as the need to streamline drug discovery and research processes continues. Automation systems help in identifying different compounds using various combinations in minimal time. They reduce the compound rejection rate through high-throughput screening. Even by having some part of the laboratory process automated, companies can significantly cut down costs and time incurred in drug discovery research. Further, the report states that reduction in R&D investment will reduce the establishment of new R&D facilities for drug discovery and innovation, thus negatively affecting the demand for automation systems. Key vendors - Danaher - PerkinElmer - Tecan Group - Thermo Fisher Other prominent vendors - Abbott Diagnostics - Agilent Technologies - Aurora Biomed - Becton, Dickinson and Co. - bioM?rieux - Biotek Instruments - Brooks Automation - Cerner - Eppendorf - Hamilton Storage Technologies - LabVantage Solutions - Labware - Olympus - Qiagen - Roche Holding - Sartorius Stedim-Biotech - Siemens Healthcare - Sotax - Xtri For more information visit http://www.researchandmarkets.com/research/fg...laboratory
A: 45.86 (+0.14), DHR: 99.03 (+0.74), PKI: 54.64 (+0.06), CERN: 55.20 (-0.02)
Global Single-use Bioprocessing System Market 2015-2019 - It is Forecasted that the Global Single-Use Bioprocessing System Market to Grow at a CAGR of 34.38% Over the Period 2014-2019
M2 - Wed Aug 19, 9:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6h7b93/global_singleuse) has announced the addition of the "Global Single-use Bioprocessing System Market 2015-2019" report to their offering. Covered in this Report The report includes the present scenario and the growth prospects of the global single-use bioprocessing system market for the period 2015-2019. To calculate the market size, we consider the revenue generated from the applications of the single-use bioprocessing system. The report, Global Single-use Bioprocessing System Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global single-use bioprocessing systems market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. One key trend emerging in the market is the increase in collaboration and partnership activities. Owing to the growing potential of the market, many bioprocessing systems manufacturers collaborate to develop new platforms for the cultivation of cells or develop new systems. According to the report, the rise in demand for bio-pharmaceuticals is one of the major drivers in this market. The increase in the aging population increases the prevalence rate of these illnesses, which increases the demand for bio-pharmaceuticals among patients. Most of these bio-pharmaceuticals are biologics and need bio-processing systems for the large-scale production of biologics to meet the needs of the industry. Key Vendors - GE Healthcare - Merck - Sartorius - Thermo Fisher Scientific Other Prominent Vendor - Broadley-James - Cellexus - Eppendorf - Finesse Solutions - Pall - Parker Hannifin - PendoTECH - Saint-Gobain - STI Components - Tarpon Biosystems Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Application 08. Geographical Segmentation 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Trends and their Impact 16. Vendor Landscape 17. Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/6h..._singleuse
MRK: 57.17 (+0.53)
Riversand Continues Strong Growth with Significant Wins and Client Go-Lives Across Industries in Q2, 2015
PRWeb - Tue Aug 04, 5:03AM CDT
Riversand Technologies, a worldwide leader of Master Data Management (MDM), Product Information Management (PIM), and Data Quality solutions, today announced that the second quarter of 2015 was another successful period of new client acquisitions and revenue growth. The company closed licensing contracts with a diverse set of new clients across multiple industries including Retail, CPG, Food & Grocery and Distribution. These results continue Riversand's strong growth trend and denote a successful 2015 for the company.
First Half of 2015: Sartorius Continues Dynamic Growth
BusinessWire - Tue Jul 21, 12:05AM CDT
--Overproportionate increase in earnings
Antibody Production Market by Product, Type, Technology & by End-User - Analysis & Global Forecast to 2019
M2 - Mon May 18, 5:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/49qvgs/antibody) has announced the addition of the "Antibody Production Market by Product, Type, Technology & by End-User - Analysis & Global Forecast to 2019" report to their offering. The global antibody production market is expected to reach $2.572 Billion in 2019 from $1.425 Billion in 2014, growing at a CAGR of 12.5%. The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the fastest rate during the forecast period. Antibodies, also known as immunoglobulins, are specialized immune proteins produced when an antigen enters the body. Antibodies are produced by the immune system in response to the presence of foreign antigens or targets such as viruses and bacteria. Antibodies can be produced using hybridoma and hybridoma-free techniques. The major types of antibodies produced are monoclonal and polyclonal antibodies. The global antibody production market is segmented on the basis of products, types, technologies, end users, and regions. By product, this market is categorized into equipment and consumables. In 2014, the consumables segment accounted for the largest share of this market. This segment is expected to grow at the fastest rate during the forecast period (2014 to 2019). On the basis of type, this market is divided into monoclonal and polyclonal antibodies. In 2014, the monoclonal antibodies segment accounted for the largest share of the market. However, the polyclonal antibodies segment is expected to grow at the fastest rate during the forecast period. The globa market, by technology, is segmented into hybridoma and hybridoma-free technologies. In 2014, the hybridoma technology segment accounted for the largest share of the market. However, the hybridoma-free technology segment is expected to grow at the fastest rate during the forecast period. This market, by end user, is segmented into biotechnology and pharmaceutical companies, diagnostic laboratories, and research institutes. The biotechnology and pharmaceutical companies segment is the largest and fastest-growing segment of the antibody production market. The key factors that are expected to spur the growth of this market are increasing demand for monoclonal antibodies globally and rising R&D expenditure of pharmaceutical and biotechnology companies. Moreover, emerging markets of India and China, rising demand for protein therapeutics, and increasing risk of pandemics and infectious diseases are likely to increase the demand for equipment and consumables used in antibody production. However, high cost of primary antibodies is likely to restrain the growth of this market. Some of the major players in the global market include GE Healthcare (U.K.), Thermo Fisher Scientific, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Sartorius AG (Germany), Merck Millipore (U.S.), Abcam plc (U.K.), Amgen (U.S.), Sanofi S.A. (France), Rockland Immunochemicals, Inc. (U.S.), and Roche Applied Science (Germany). For more information visit http://www.researchandmarkets.com/research/49qvgs/antibody
SIAL: 139.97 (+0.21), MRK: 57.17 (+0.53), AMGN: 160.19 (+1.00)
Industrial Microbiology Market Review: Global Review of Microbiology Testing in the Industrial Market
M2 - Fri May 15, 4:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ttmpkp/industrial) has announced the addition of the "Industrial Microbiology Market Review 4th Edition" report to their offering. Industrial Microbiology Market Review, Fourth Edition: Global Review of Microbiology Testing in the Industrial Market (IMMR-4) is a new, extensively researched analysis of the sizable market for microbiological testing in the industrial market. IMMR-4 tracks and compares microbiology test volumes, market values and methods used by companies in the production of safe and wholesome products that meet label claims. IMMR-4 includes global test volumes and growth in industrial microbiology with further analysis of market sectors, geographic regions, test methods, organisms tested and sample sources. Current market values are detailed as well as projected through 2019. With five-year projections of both testing volumes and market value, IMMR-4 provides critical input to strategic planning. We conducted more than 650 detailed interviews in 23 countries around the world as input to IMMR-4. Close to one-third of the interviews were conducted in six countries of Asia (China, India, Indonesia, Thailand, Singapore and Vietnam) due to the region's economic importance, in both production and consumption, in the industrial market sectors. IMMR-4 is based on primary research with the quality assurance managers of production facilities in six sectors of the industrial microbiology market: - Food - Beverage - Pharmaceuticals - Personal Care Products and Cosmetics (including new coverage of the fast-growing Nutraceuticals market) - Environmental Water - Industrial Processes Five additional appendices are available for purchase at an extra cost with IMMR-4, to add even greater detail in the following areas: - Organism Review - Methods Review - Food Sector Review - Pharmaceuticals/Personal Care Products Sectors Review - Review of Microbial Identification Key Topics Covered: Section 1: Preface Section 2: Executive Summary Section 3: Market Trends/Drivers Section 4: Industrial Microbiology Market (IMM) Summary-2014 Section 5: Industrial Microbiology Market (IMM) Projections-2019 Section 6: Food Sector Review Section 7: Beverage Sector Review Section 8: Pharmaceutical Sector Review Section 9: Personal Care Products (PCP) Sector Review Section 10: Environmental Water Sector Review Section 11: Industrial Process Sector Review Section 12: Diagnostics (Dx) Business Review Section 13: Diagnostic Company Reviews Section 14: Market Structure/Methodology Companies Mentioned - 3M - Becton-Dickinson - Bio-Rad - BioControl - Celsis - Charles River - DuPont - EMD Millipore - HI Media - Hardy Diagnostics - IDEXX - Lonza - Neogen - Pall Corporation - QIAGEN - Rapid Micro Biosystems - Roka Bioscience - Sartorius/Stedim - ThermoFisher Scientific For more information visit http://www.researchandmarkets.com/research/ttmpkp/industrial
ROKA: 0.75 (+0.01), PLL: 127.11 (-0.01), NEOG: 52.01 (+0.95)
Sartorius Starts Off Fiscal 2015 with a Strong First Quarter
BusinessWire - Mon Apr 20, 12:00AM CDT
--Further significant increase in earnings
SRT: 4.30 (-0.06)
Sartorius AG: Dynamic First Quarter | Forecast Revised Upwards
BusinessWire - Tue Apr 14, 8:28AM CDT
In the first quarter of 2015, the Sartorius Group achieved sales growth of around 17% in constant currencies based on preliminary figures, reaching approximately EUR258 million in consolidated revenue (reported gain: around 27%).
Sartorius to Implement Stock Split on June 13, 2016
BusinessWire - Thu Jun 02, 2:10PM CDT
As approved by the Annual Shareholders' Meeting of Sartorius AG (FWB:SRT) on April 7, the capital increase by use of retained earnings to perform a stock split will be implemented on June 13, 2016. Every shareholder will receive three additional shares of the same type per share held, without an additional payment. The stock split is intended to encourage trading with Sartorius shares and make them attractive to even broader groups of investors.
SRT: 4.30 (-0.06)
Agile MDM for Global Multi-Channel PIM - Case Study to be Presented at International MDM Summit, London May 16th - 19th
PRWeb - Mon Apr 25, 2:10PM CDT
Riversand Technologies, a worldwide leader in Multi-Domain Master Data Management (MDM), Product Information Management, and Data Quality solutions, will be sponsoring the MDM Summit and DG Conference in London, May 16th - 19th. Nicholas Rioux, CTO & Senior Partner at enscight, and Colin Price, PIM Manager at Sartorius, a Riversand client will present "Agile MDM for Global Multi-Channel PIM" at the event.
Virus Filtration Market - Global Forecast to 2020 - Key Players are Lonza Group, Sigma-Aldrich & Sartorius AG - Research and Markets
BusinessWire - Wed Apr 20, 9:22AM CDT
Research and Markets has announced the addition of the "Virus Filtration Market - Global Forecast to 2020" report to their offering.
Q1 Results: Sartorius Off to a Dynamic Start in 2016
BusinessWire - Wed Apr 20, 12:05AM CDT
--Overproportionate increase in earnings
SRT: 4.30 (-0.06)
Laboratory Glassware and Plasticware Market - Forecast to 2020 - Key Players are Corning, Eppendorf & Sartorius AG - Research and Markets
BusinessWire - Fri Apr 08, 7:56AM CDT
Research and Markets has announced the addition of the "Laboratory Glassware and Plasticware Market - Forecast to 2020" report to their offering.
Worldwide Bioreactors Market Report 2015-2019
Marketwired - Mon Apr 04, 7:23AM CDT
Research and Markets has announced the addition of the "The Worldwide Market for Bioreactors" report to their offering.
DHR: 99.03 (+0.74)
Sartorius Grows by Double Digits in Sales and Profit in 2015 - Positive Outlook for 2016 - Targets for 2020 Updated
BusinessWire - Mon Feb 01, 12:05AM CST
--Number of staff increased by around 10% to around 6,200
Global PTFE Membrane - Estimated to Reach $1.48 Billion By 2020 at a CAGR Of 7.7%
M2 - Tue Jan 12, 3:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/p7k366/ptfe_membrane) has announced the addition of the "PTFE Membrane Market - Trends & Forecasts to 2020" report to their offering. The global PTFE membrane market is estimated to reach $1.48 Billion by 2020 at a CAGR of 7.7%. The market is driven by growing prominence for water & waste water treatment and increasing penetration with evolving medical & pharmaceutical industry. The market includes two types of PTFE membrane - Hydrophobic PTFE membrane and Hydrophilic PTFE membrane. PTFE membrane is used in various applications such as water & waste water treatment, filtration, medical & pharmaceutical, textile, architecture, and others.These are the main applications considered in the report. Asia-Pacific, North America, Europe, and RoW are considered the main regions for PTFE membrane market in the report. Asia-Pacific region is dominant in the market and will be the fastest growing region for the forecast period of 2015 and 2020. The rising sale of PTFE membrane in this region is mainly driven by its strong demand in filtration application. Though the market is growing at a significant growth rate, few factors hinder the growth of the market globally. The higher price of raw materials, shift of end-user market from developed countries to the developing countries, and fluctuations in the currency exchange rates of Japan are the major restraints toward the growth of the PTFE membrane market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Membrane Market 8 Membrane Market, By Type 9 Membrane Market, By Applications 10 Membrane Market, By Region 11 Competitive Landscape 12 Company Profile - Corning Inc. - Donaldson Filtration Solutions - General Electric Company - Hyundai Micro Co., Ltd. - Layne Christensen Company - Markel Corporation - Merck Millipore - Pall Corporation - Sartorius AG - W.L. Gore & Associates, Inc. - Zeus Incorporation For more information visit http://www.researchandmarkets.com/research/p7...e_membrane
GE: 30.12 (+0.18), PLL: 127.11 (-0.01), LAYN: 8.84 (-0.09), MRK: 57.17 (+0.53), MKL: 953.37 (-9.64)
Global Pharmaceutical Membrane Market Report 2015-2019 - Growth of the Pharmaceutical Industry Drives the Market
M2 - Tue Oct 20, 5:58AM CDT
Research and Markets (http://www.researchandmarkets.com/research/s2xr6h/global_membrane) has announced the addition of the "Global Membrane Market in Pharmaceutical Industry 2015-2019" report to their offering. The global membrane market in pharmaceutical industry to grow at a CAGR of 12.46%, in terms of revenue, during 2014-2019. The report includes the present scenario and the growth prospects of the global membrane market in pharmaceutical industry for the period 2015-2019. The market can be segmented into two divisions: Technology and applications. The report covers the Americas, APAC, and EMEA markets and also includes the key vendors operating in the market. Membranes are increasingly becoming an integral part of many pharmaceutical manufacturing processes and water management systems. Various developments in membrane technology and materials such as perfluoropolymer, solid polymer electrolyte, nonporous nanofiltration and fouling-resistant multilayer membranes will positively affect the growth of the market. Also the increase in market competition is forcing vendors to increase their focus on R&D to provide high-quality and technically advanced membrane systems with additional control features that can be easily maintained by end-users throughout their life cycle. However, prices of certain products needed to carry out the research are high, making it difficult for manufacturers to manage their R&D costs. According to the report, the pharmaceutical industry involves the production, development, and marketing of medications. The industry is growing rapidly with the increasing need for and complexity of medication. The aging population, changing lifestyles, and increased chronic diseases are some of the major factors which have increased the demand for pharmaceuticals and led to the growth of this industry. Apart from this, robust economic growth, greater marketing penetration into extra-urban and rural areas, epidemiological changes, continuing rapid expansion of the private hospital sector, and increased government spending on improvements in healthcare infrastructure and spending are also driving the growth of the industry. Further, the report states that the process of setting up new production facilities for the manufacture of membrane requires high investment. Key Vendors - EMD Millipore - GEA Filtration - GE Healthcare - Koch Membrane Systems - Sartorius - Spectrum Laboratories Other Prominent Vendors - Applied Membrane Tech - Veolia Water Technologies - Pall Corporation - Graver Technologies - TAMI Industries For more information visit http://www.researchandmarkets.com/research/s2...l_membrane
PLL: 127.11 (-0.01)
Nine-month Figures for 2015: Sartorius Grows in Strong Double Digits in Order Intake, Sales Revenue and Earnings
BusinessWire - Tue Oct 20, 12:05AM CDT
--Overproportionate increase in earnings
SRT: 4.30 (-0.06)
The Worldwide Market for Bioreactors, 2019
M2 - Tue Sep 22, 4:06AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hwnvhw/the_worldwide) has announced the addition of the "The Worldwide Market for Bioreactors" report to their offering. The Worldwide Market for Bioreactors analyzes the current and potential world markets for bioreactors used generally for research and preclinical development applications, and for the manufacture of biopharmaceuticals. The cost of production can take on a significant role in the pricing of a biologic. Often, the selection of a bioreactor is a critical manufacturing decision. Selection is often done on a case-by-case basis and depends on production requirements. The industry's turn to single use bioreactors and related technology comes at a time when bioprocessors look to be flexible with production and to minimize costs. The report looks at significant trends in single use bioreactors. This report offers market forecasts of future growth to 2019. Both single use and stainless steel bioreactor markets are analyzed, with worldwide and geographic forecasts, including the U.S., Europe, Asia, Latin America, and rest of world. The report takes an in-depth look at the market, providing data on the size and growth of the total market as well as of market segments: Single Use Bioreactor Market Share by Type of Molecule, 2014 (monoclonal antibodies, vaccines, gene therapy, recombinant proteins, stem cells, others) - World Market for Bioreactors - Single Use Technology, 2014-2019 - World Market for Bioreactors - Single Use Technology, 2014-2019, by Geographic Segment - World Market for Bioreactors - Single Use Technology, 2015, by Geographic Segment - Percentage of Marketed Therapeutics by System, 2014 - Single Use Bioreactor Market Share by Vendor, 2014 - Single Use Bioreactor Usage by Process, 2014 - World Market for Bioreactors - Stainless Steel, 2014-2019 - World Market for Bioreactors - Stainless Steel, 2014-2019, by Geographic Segment - World Market for Bioreactors - Stainless Steel, 2015, by Geographic Segment Key Topics Covered: 1.0 Executive Summary 2.0 Introduction 3.0 Single Use Trends 4.0 Corporate Acquisitions 5.0 Market Developments 6.0 Market Perspective 7.0 Corporate Profiles - Applikon Biotechnology - Bioengineering AG - Broadley-James Corp. - Cellexus Ltd. - Celltainer Biotech BV - CerCell ApS - Electrolab Biotech Ltd. - Eppendorf - Finesse Solutions - GE Healthcare's Life Sciences Business - Heinrich Frings GmbH & Co. KG - Infors AG - Life Technologies - New MBR - Millipore - Pall Biopharm - PBS Biotech Inc. - Pierre Guerin Technologies Usine - Pluristem Therapeutics Inc. - Sartorius AG - Techniserv Inc. - Zeta Holding GmbH For more information visit http://www.researchandmarkets.com/research/hw..._worldwide
LIFE: 3.49 (+0.02), PSTI: 1.56 (-0.01)
Global Laboratory Automation Market 2015-2019 with Danaher, PerkinElmer, Tecan Group & Thermo Fisher Dominating
M2 - Wed Sep 09, 9:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fg5dnq/global_laboratory) has announced the addition of the "Global Laboratory Automation Market 2015-2019" report to their offering. The global laboratory automation market to grow at a CAGR of 5.48% over the period 2014-2019. This report covers the present scenario and the growth prospects of the global laboratory automation market for the period 2015-2019. To calculate the market size, the report covers revenue generated from its application in clinical laboratory and drug discovery laboratory. The report, Global Laboratory Automation Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, and North America, It also presents the vendor landscape and a corresponding detailed analysis of the major vendors in the market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market. The growing adoption of microfluidic chips or lab-on chips is one of the most significant engineering advances in recent years. Microfluidic chips are used in advanced biological research such as proteomics, genomics, and metabolic research. The global microfluidic chips market is growing because of their increased use in major laboratories worldwide. This is expected to drive the development of new laboratory automation systems over the next few years. This, in turn, should drive the growth of the global laboratory automation market during the forecast period. According to the report, the drug discovery market should experience slow growth as many pharmaceutical companies have cut down their R&D spending. However, this should not have a significant effect on the automation market in drug discovery laboratories as the need to streamline drug discovery and research processes continues. Automation systems help in identifying different compounds using various combinations in minimal time. They reduce the compound rejection rate through high-throughput screening. Even by having some part of the laboratory process automated, companies can significantly cut down costs and time incurred in drug discovery research. Further, the report states that reduction in R&D investment will reduce the establishment of new R&D facilities for drug discovery and innovation, thus negatively affecting the demand for automation systems. Key vendors - Danaher - PerkinElmer - Tecan Group - Thermo Fisher Other prominent vendors - Abbott Diagnostics - Agilent Technologies - Aurora Biomed - Becton, Dickinson and Co. - bioM?rieux - Biotek Instruments - Brooks Automation - Cerner - Eppendorf - Hamilton Storage Technologies - LabVantage Solutions - Labware - Olympus - Qiagen - Roche Holding - Sartorius Stedim-Biotech - Siemens Healthcare - Sotax - Xtri For more information visit http://www.researchandmarkets.com/research/fg...laboratory
A: 45.86 (+0.14), DHR: 99.03 (+0.74), PKI: 54.64 (+0.06), CERN: 55.20 (-0.02)
Global Single-use Bioprocessing System Market 2015-2019 - It is Forecasted that the Global Single-Use Bioprocessing System Market to Grow at a CAGR of 34.38% Over the Period 2014-2019
M2 - Wed Aug 19, 9:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6h7b93/global_singleuse) has announced the addition of the "Global Single-use Bioprocessing System Market 2015-2019" report to their offering. Covered in this Report The report includes the present scenario and the growth prospects of the global single-use bioprocessing system market for the period 2015-2019. To calculate the market size, we consider the revenue generated from the applications of the single-use bioprocessing system. The report, Global Single-use Bioprocessing System Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global single-use bioprocessing systems market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. One key trend emerging in the market is the increase in collaboration and partnership activities. Owing to the growing potential of the market, many bioprocessing systems manufacturers collaborate to develop new platforms for the cultivation of cells or develop new systems. According to the report, the rise in demand for bio-pharmaceuticals is one of the major drivers in this market. The increase in the aging population increases the prevalence rate of these illnesses, which increases the demand for bio-pharmaceuticals among patients. Most of these bio-pharmaceuticals are biologics and need bio-processing systems for the large-scale production of biologics to meet the needs of the industry. Key Vendors - GE Healthcare - Merck - Sartorius - Thermo Fisher Scientific Other Prominent Vendor - Broadley-James - Cellexus - Eppendorf - Finesse Solutions - Pall - Parker Hannifin - PendoTECH - Saint-Gobain - STI Components - Tarpon Biosystems Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Application 08. Geographical Segmentation 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Trends and their Impact 16. Vendor Landscape 17. Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/6h..._singleuse
MRK: 57.17 (+0.53)
Riversand Continues Strong Growth with Significant Wins and Client Go-Lives Across Industries in Q2, 2015
PRWeb - Tue Aug 04, 5:03AM CDT
Riversand Technologies, a worldwide leader of Master Data Management (MDM), Product Information Management (PIM), and Data Quality solutions, today announced that the second quarter of 2015 was another successful period of new client acquisitions and revenue growth. The company closed licensing contracts with a diverse set of new clients across multiple industries including Retail, CPG, Food & Grocery and Distribution. These results continue Riversand's strong growth trend and denote a successful 2015 for the company.
First Half of 2015: Sartorius Continues Dynamic Growth
BusinessWire - Tue Jul 21, 12:05AM CDT
--Overproportionate increase in earnings
Antibody Production Market by Product, Type, Technology & by End-User - Analysis & Global Forecast to 2019
M2 - Mon May 18, 5:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/49qvgs/antibody) has announced the addition of the "Antibody Production Market by Product, Type, Technology & by End-User - Analysis & Global Forecast to 2019" report to their offering. The global antibody production market is expected to reach $2.572 Billion in 2019 from $1.425 Billion in 2014, growing at a CAGR of 12.5%. The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the fastest rate during the forecast period. Antibodies, also known as immunoglobulins, are specialized immune proteins produced when an antigen enters the body. Antibodies are produced by the immune system in response to the presence of foreign antigens or targets such as viruses and bacteria. Antibodies can be produced using hybridoma and hybridoma-free techniques. The major types of antibodies produced are monoclonal and polyclonal antibodies. The global antibody production market is segmented on the basis of products, types, technologies, end users, and regions. By product, this market is categorized into equipment and consumables. In 2014, the consumables segment accounted for the largest share of this market. This segment is expected to grow at the fastest rate during the forecast period (2014 to 2019). On the basis of type, this market is divided into monoclonal and polyclonal antibodies. In 2014, the monoclonal antibodies segment accounted for the largest share of the market. However, the polyclonal antibodies segment is expected to grow at the fastest rate during the forecast period. The globa market, by technology, is segmented into hybridoma and hybridoma-free technologies. In 2014, the hybridoma technology segment accounted for the largest share of the market. However, the hybridoma-free technology segment is expected to grow at the fastest rate during the forecast period. This market, by end user, is segmented into biotechnology and pharmaceutical companies, diagnostic laboratories, and research institutes. The biotechnology and pharmaceutical companies segment is the largest and fastest-growing segment of the antibody production market. The key factors that are expected to spur the growth of this market are increasing demand for monoclonal antibodies globally and rising R&D expenditure of pharmaceutical and biotechnology companies. Moreover, emerging markets of India and China, rising demand for protein therapeutics, and increasing risk of pandemics and infectious diseases are likely to increase the demand for equipment and consumables used in antibody production. However, high cost of primary antibodies is likely to restrain the growth of this market. Some of the major players in the global market include GE Healthcare (U.K.), Thermo Fisher Scientific, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Sartorius AG (Germany), Merck Millipore (U.S.), Abcam plc (U.K.), Amgen (U.S.), Sanofi S.A. (France), Rockland Immunochemicals, Inc. (U.S.), and Roche Applied Science (Germany). For more information visit http://www.researchandmarkets.com/research/49qvgs/antibody
SIAL: 139.97 (+0.21), MRK: 57.17 (+0.53), AMGN: 160.19 (+1.00)
Industrial Microbiology Market Review: Global Review of Microbiology Testing in the Industrial Market
M2 - Fri May 15, 4:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ttmpkp/industrial) has announced the addition of the "Industrial Microbiology Market Review 4th Edition" report to their offering. Industrial Microbiology Market Review, Fourth Edition: Global Review of Microbiology Testing in the Industrial Market (IMMR-4) is a new, extensively researched analysis of the sizable market for microbiological testing in the industrial market. IMMR-4 tracks and compares microbiology test volumes, market values and methods used by companies in the production of safe and wholesome products that meet label claims. IMMR-4 includes global test volumes and growth in industrial microbiology with further analysis of market sectors, geographic regions, test methods, organisms tested and sample sources. Current market values are detailed as well as projected through 2019. With five-year projections of both testing volumes and market value, IMMR-4 provides critical input to strategic planning. We conducted more than 650 detailed interviews in 23 countries around the world as input to IMMR-4. Close to one-third of the interviews were conducted in six countries of Asia (China, India, Indonesia, Thailand, Singapore and Vietnam) due to the region's economic importance, in both production and consumption, in the industrial market sectors. IMMR-4 is based on primary research with the quality assurance managers of production facilities in six sectors of the industrial microbiology market: - Food - Beverage - Pharmaceuticals - Personal Care Products and Cosmetics (including new coverage of the fast-growing Nutraceuticals market) - Environmental Water - Industrial Processes Five additional appendices are available for purchase at an extra cost with IMMR-4, to add even greater detail in the following areas: - Organism Review - Methods Review - Food Sector Review - Pharmaceuticals/Personal Care Products Sectors Review - Review of Microbial Identification Key Topics Covered: Section 1: Preface Section 2: Executive Summary Section 3: Market Trends/Drivers Section 4: Industrial Microbiology Market (IMM) Summary-2014 Section 5: Industrial Microbiology Market (IMM) Projections-2019 Section 6: Food Sector Review Section 7: Beverage Sector Review Section 8: Pharmaceutical Sector Review Section 9: Personal Care Products (PCP) Sector Review Section 10: Environmental Water Sector Review Section 11: Industrial Process Sector Review Section 12: Diagnostics (Dx) Business Review Section 13: Diagnostic Company Reviews Section 14: Market Structure/Methodology Companies Mentioned - 3M - Becton-Dickinson - Bio-Rad - BioControl - Celsis - Charles River - DuPont - EMD Millipore - HI Media - Hardy Diagnostics - IDEXX - Lonza - Neogen - Pall Corporation - QIAGEN - Rapid Micro Biosystems - Roka Bioscience - Sartorius/Stedim - ThermoFisher Scientific For more information visit http://www.researchandmarkets.com/research/ttmpkp/industrial
ROKA: 0.75 (+0.01), PLL: 127.11 (-0.01), NEOG: 52.01 (+0.95)
Sartorius Starts Off Fiscal 2015 with a Strong First Quarter
BusinessWire - Mon Apr 20, 12:00AM CDT
--Further significant increase in earnings
SRT: 4.30 (-0.06)
Sartorius AG: Dynamic First Quarter | Forecast Revised Upwards
BusinessWire - Tue Apr 14, 8:28AM CDT
In the first quarter of 2015, the Sartorius Group achieved sales growth of around 17% in constant currencies based on preliminary figures, reaching approximately EUR258 million in consolidated revenue (reported gain: around 27%).
